论文部分内容阅读
近年来,急性白血病缓解率的显著提高,生存期的明显延长,主要是由于积极而联合地使用化疗,有效抗菌素的合理应用,成分输血等强力支持治疗的结果。但是,我们在临床上经常可以遇到这种情况,即使在同样的治疗条件下,患者的疗效也是不完全相同的,也就是说疗效还与某些其他因素有关。设法测定和合理分析某些影响因素,进而设法克服那些不利因素,根据患者的具体情况制定更为恰当的治疗方案,对进一步提高急性白血病的疗效是有益的。 1980年8月在18届国际血液学会和16届国际输血学会亦谈到,目前似乎有一部分化疗方案能治愈一些急性非淋巴细胞性白血
In recent years, the remission rate of acute leukemia significantly increased, significantly prolonged survival, mainly due to active and joint use of chemotherapy, the rational use of effective antibiotics, blood transfusions and other strong supportive treatment results. However, we often encounter this condition clinically, even in the same treatment conditions, the patient’s efficacy is not exactly the same, which means that the efficacy is also related to some other factors. Trying to measure and reasonably analyze some influencing factors and then try to overcome those unfavorable factors and make a more appropriate treatment plan according to the patients’ specific conditions is beneficial to further improve the curative effect of acute leukemia. August 1980 at the 18th International Society of Hematology and the 16th International Society of Blood Transfusion also mentioned that at present there seems to be a part of the chemotherapy regimen can cure some acute non-lymphocytic leukemia